Myopia control means
    1.
    发明授权

    公开(公告)号:US10156737B2

    公开(公告)日:2018-12-18

    申请号:US15416674

    申请日:2017-01-26

    摘要: Sets, kits or stocks of anti-myopia lenses and methods for their use, that do not require a clinician to measure peripheral refractive error in the eyes of myopic patients. Lenses having peripheral powers or defocus set in accordance with central corrective power will cover almost all normal myopes not worse than −6D central refractive error. For example, a kit or set of lenses (50, FIG. 15) can have multiple parts or sub-sets each with a compartmented container with lenses arranged according to increments of central corrective power. The lenses of the first part have four steps of peripheral power or defocus to provide therapeutic effect and, while the lenses of the second part also have four steps, the level of therapeutic effect is higher. Other examples of sets, kits and stocks, as well as examples of lenses themselves, are disclosed together with methods of use.

    MYOPIA CONTROL MEANS
    2.
    发明申请
    MYOPIA CONTROL MEANS 有权
    MYOPIA控制手段

    公开(公告)号:US20140132933A1

    公开(公告)日:2014-05-15

    申请号:US14160393

    申请日:2014-01-21

    IPC分类号: G02C7/04 G02C7/06

    摘要: Sets, kits or stocks of anti-myopia contact or spectacle lenses, along with methods for their use, that do not require a clinician to measure peripheral refractive error in the eyes of myopic patients. Extensive surveys have shown that lenses having peripheral powers or defocus set in accordance with central corrective power will cover almost all normal myopes not worse than −6D central refractive error. In one example, a kit or set of lenses (50, FIG. 15) can have multiple parts or sub-sets (52, 54) each comprising a compartmented container (56a, 56b) with lenses (58a, 58b) arranged according to increments of central corrective power (59a, 59b). The lenses (58a) of the first part (52) have four steps (60a, 61a, 62a, 64a) of peripheral power or defocus to provide therapeutic effect and, while the lenses (58b) of the second part (54) also have four steps (60b, 61b, 62b, 64b), the level of therapeutic effect is higher. Other examples of sets, kits and stocks, as well as examples of lenses themselves, are disclosed together with methods of use.

    摘要翻译: 抗近视接触眼镜镜片的套件,套件或库存,以及使用方法,不需要临床医生测量近视患者眼睛的周边屈光不正。 广泛的调查显示,具有根据中心矫正力设置的外围功率或散焦的镜片将覆盖几乎所有正常的近视眼,不会比-6D中心屈光不正差。 在一个示例中,套件或一组透镜(50,图15)可以具有多个部件或子组件(52,54),每个部件或子组件包括具有透镜(58a,58b)的分隔的容器(56a,56b) 中央矫正力的增量(59a,59b)。 第一部分(52)的透镜(58a)具有周边功率或散焦的四个台阶(60a,61a,62a,64a)以提供治疗效果,并且当第二部分(54)的透镜(58b)也具有 四个步骤(60b,61b,62b,64b),治疗效果水平较高。 集合,套件和股票的其他示例以及透镜本身的示例与所使用的方法一起公开。

    Myopia control means
    3.
    发明授权
    Myopia control means 有权
    近视控制手段

    公开(公告)号:US09594257B2

    公开(公告)日:2017-03-14

    申请号:US14160393

    申请日:2014-01-21

    IPC分类号: G02C7/02 G02C7/04 G02C7/06

    摘要: Sets, kits or stocks of anti-myopia contact or spectacle lenses, along with methods for their use, that do not require a clinician to measure peripheral refractive error in the eyes of myopic patients. Extensive surveys have shown that lenses having peripheral powers or defocus set in accordance with central corrective power will cover almost all normal myopes not worse than −6D central refractive error. In one example, a kit or set of lenses (50, FIG. 15) can have multiple parts or sub-sets (52, 54) each comprising a compartmented container (56a, 56b) with lenses (58a, 58b) arranged according to increments of central corrective power (59a, 59b). The lenses (58a) of the first part (52) have four steps (60a, 61a, 62a, 64a) of peripheral power or defocus to provide therapeutic effect and, while the lenses (58b) of the second part (54) also have four steps (60b, 61b, 62b, 64b), the level of therapeutic effect is higher. Other examples of sets, kits and stocks, as well as examples of lenses themselves, are disclosed together with methods of use.

    摘要翻译: 抗近视接触眼镜镜片的套件,套件或库存,以及使用方法,不需要临床医生测量近视患者眼睛的周边屈光不正。 广泛的调查显示,具有根据中心矫正力设置的外围功率或散焦的镜片将覆盖几乎所有正常的近视眼,不会比-6D中心屈光不正差。 在一个示例中,套件或一组透镜(50,图15)可以具有多个部件或子组件(52,54),每个部件或子组件包括具有透镜(58a,58b)的分隔的容器(56a,56b),根据 中央矫正力的增量(59a,59b)。 第一部分(52)的透镜(58a)具有周边功率或散焦的四个台阶(60a,61a,62a,64a),以提供治疗效果,并且当第二部分(54)的透镜(58b)也具有 四个步骤(60b,61b,62b,64b),治疗效果水平较高。 集合,套件和股票的其他示例以及透镜本身的示例与所使用的方法一起公开。